Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

A subpopulation of smooth muscle cells, derived from melanocyte-competent precursors, prevents patent ductus arteriosus.

Yajima I, Colombo S, Puig I, Champeval D, Kumasaka M, Belloir E, Bonaventure J, Mark M, Yamamoto H, Taketo MM, Choquet P, Etchevers HC, Beermann F, Delmas V, Monassier L, Larue L.

PLoS One. 2013;8(1):e53183. doi: 10.1371/journal.pone.0053183. Epub 2013 Jan 31.

2.

Prostaglandin E-mediated molecular mechanisms driving remodeling of the ductus arteriosus.

Yokoyama U.

Pediatr Int. 2015 Oct;57(5):820-7. doi: 10.1111/ped.12769. Review.

PMID:
26228894
3.

[Phenotypic plasticity of neural crest-derived melanocytes and Schwann cells].

Dupin E.

Biol Aujourdhui. 2011;205(1):53-61. doi: 10.1051/jbio/2011008. Epub 2011 Apr 19. Review. French.

PMID:
21501576
4.

Insights into the pathogenesis and genetic background of patency of the ductus arteriosus.

Bökenkamp R, DeRuiter MC, van Munsteren C, Gittenberger-de Groot AC.

Neonatology. 2010 Jun;98(1):6-17. doi: 10.1159/000262481. Epub 2009 Dec 2. Review.

PMID:
19955832
5.

Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated?

Laughon MM, Simmons MA, Bose CL.

Curr Opin Pediatr. 2004 Apr;16(2):146-51. Review.

PMID:
15021192
6.

The patent ductus arteriosus in term infants, children, and adults.

Schneider DJ.

Semin Perinatol. 2012 Apr;36(2):146-53. doi: 10.1053/j.semperi.2011.09.025. Review.

PMID:
22414886
7.

Patent ductus arteriosus of the preterm infant.

Hamrick SE, Hansmann G.

Pediatrics. 2010 May;125(5):1020-30. doi: 10.1542/peds.2009-3506. Epub 2010 Apr 26. Review.

PMID:
20421261
8.

Clinical pharmacology of indomethacin in preterm infants: implications in patent ductus arteriosus closure.

Pacifici GM.

Paediatr Drugs. 2013 Oct;15(5):363-76. doi: 10.1007/s40272-013-0031-7. Review.

PMID:
23754139
9.

Regulation of vascular tone and remodeling of the ductus arteriosus.

Yokoyama U, Minamisawa S, Ishikawa Y.

J Smooth Muscle Res. 2010;46(2):77-87. Review.

10.

Patent ductus arteriosus in the preterm infant.

Kirsten D.

Neonatal Netw. 1996 Mar;15(2):19-26. Review.

PMID:
8700090
11.

Pharmacologic management of patent ductus arteriosus.

Bhatt V, Nahata MC.

Clin Pharm. 1989 Jan;8(1):17-33. Review.

PMID:
2643499
12.

Genetics of patent ductus arteriosus susceptibility and treatment.

Hajj H, Dagle JM.

Semin Perinatol. 2012 Apr;36(2):98-104. doi: 10.1053/j.semperi.2011.09.019. Review.

PMID:
22414880
13.

Mechanisms of oxygen sensing: a key to therapy of pulmonary hypertension and patent ductus arteriosus.

Weir EK, Obreztchikova M, Vargese A, Cabrera JA, Peterson DA, Hong Z.

Br J Pharmacol. 2008 Oct;155(3):300-7. doi: 10.1038/bjp.2008.291. Epub 2008 Jul 21. Review.

14.

Ductus-dependent fetal cardiac defects contraindicate indomethacin tocolysis.

Saenger JS, Mayer DC, D'Angelo LJ, Manci EA.

J Perinatol. 1992 Mar;12(1):41-7. Review.

PMID:
1560290
15.
16.

Chest shielding for prevention of a haemodynamically significant patent ductus arteriosus in preterm infants receiving phototherapy.

Bhola K, Foster JP, Osborn DA.

Cochrane Database Syst Rev. 2015 Nov 3;(11):CD009816. doi: 10.1002/14651858.CD009816.pub2. Review.

PMID:
26523368
17.

Patent Ductus Arteriosus.

Gillam-Krakauer M, Bhimji S.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.
2017 Jul 11.

Supplemental Content

Support Center